MEDICAL EDUCATION:
Dr. Hasmik L. Ghazinyan graduated from Yerevan State Medical University named after Mkhitar Heratsi in 1978. Later, in 1987 she received specialization certificate from the Chair of Infections Disease of the National Institute of Health Named After Academician S. AVDALBEKYAN (NIH), Ministry of Health of the Republic of Armenia.
Dr. Ghazinyan also completed a post-graduation study and Fellowship Program on Infections Diseases in Olbany Medical center, NY, USA, 1996.

CURRENT ACADEMIC OR ADMINISTRATIVE POSITION:
National Centre of Infectious Diseases: Head of Hepatological Clinic
Medical University after Saint Teresa, Yerevan: Head of Epidemiology and Infectious Diseases Department

AREA OF RESEARCH INTERESTS:
Viral Hepatitis, HBV, HCV, HCC, NAFLD/NASH, ACLF, Cirrhosis

 PUBLICATRION AND PRESENTATIONS:
Dr. Hasmik Ghazinyan is an author of more than 194 scientific publications in local and international journals. She attended more than 120 specialized medical conferences (local and international) as an invited speaker and moderator.

COMMENTS:
Dr. Hasmik L. Ghazinyan – Hepatologist, MD., Ph.D

• Head of Hepatological Clinic,  National Centre for Infectious  Diseases, Yerevan, Armenia
• President of Armenian Association for the Study of the Liver (ARASL)
• Member of EASL, AASLD, APASL, IASL, CEVHAP ·
• Member of Editorial Advisory council of scientific-practical journal Blood Armenia, since 2011
• Member of Editorial Advisory council of scientific- practical journal Actual Infectology, Ukraine since 1 August 2013
• Member of Editorial board of journal of Clinical and Molecular Hepatology of Korean Association for the Study of the Liver (KASL), since 2015
• Author of Methodical Recommendations: Management of HBV and HCV Infections in Onco/Oncoheamatological Patients in the Republic of Armenia
• Member of APASL executive Council (EC) 2017-2019
• Invited specialist in Editorial Board Members of Medical Journal of Viral Hepatitis
• Member of APASL ACLF Research Consortium (AARC) working group,.
• Member of the APASL guidelines development committee for Hepatitis B in Pregnancy
• Clinical practice guidance for hepatology and liver transplant
  Providers during the COVID‑19 pandemic: APASL expert panel consensus recommendations (2021)
• Member of Global Nash Council
• Member of EASL ILF (Country Survey Lead)

Member of APASL Guidelines on:

• Clinical Practice Guideline on hepatitis B Reactivation-2021 HBVr (23/3/2021)
• Liver failure determines the outcome in patients of acute-on chronic liver failure (ACLF):
  Comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models
• Acute-on-Chronic liver failure: consensus recommendations of the AsianPacificAssociation for the study of the liver (APASL): an update 2019

 Invited Guest as a Speaker/Chair, APASL 2022, Seoul
 Invited Guest as a Speaker/Chair, APASL  Oncology  in Takamatsu  2022

 Invited Guest as a Chair, APASL STC 2022 Egypt 

President of APASL STC on NAFLD/NASH in Yerevan, Armenia, October 2022